Vireo Growth Inc. 8K

Vireo Growth Inc. reported sharply higher Q2 2026 results driven by numerous completed and pending acquisitions, a major Planet 13 merger agreement, new state entries, and a new revolving credit facility that together position it as a leading U.S. cannabis operator by scale and dispensary count.

Vireo Growth Inc. reported a transformational second quarter ended June 30, 2026, with GAAP revenue rising 335% year-over-year to $209.3 million and adjusted EBITDA increasing to $41.5 million, driven by an aggressive M&A and integration strategy that closed acquisitions of Hawthorne, Eaze, Bridgewell and certain PharmaCann assets, announced acquisitions of FLUENT, C21, Cannabist assets, multiple Ohio businesses, a joint venture with Glass House, and an all-stock merger agreement with Planet 13, while also securing a new asset-based revolving credit facility of up to $105 million and positioning itself to become the largest U.S. cannabis operator by dispensary count. The company expanded into or deepened operations in numerous states (including California, Florida, Nevada, Colorado, Pennsylvania, Illinois, Massachusetts, New Jersey, and Ohio), launched a non-cannabis agribusiness segment through Hawthorne and Bridgewell, executed a 30-to-1 share consolidation, changed auditors to BDO USA, and ended the quarter with $122.7 million of cash and $374.0 million of current assets (excluding income taxes receivable), highlighting both rapid scale-up and a more complex balance sheet, including higher debt and contingent consideration. Management emphasized that future value creation will depend on disciplined capital allocation, operational excellence, and successful integration of these acquisitions through 2027, as it aims to build multiple $100 million-plus businesses across core markets and fully realize the earnings power of its broadened cannabis and agribusiness platform.

Filing Facts

CIK

1771706

Ticker

-

Form

8K

Source Type

sec

Accession

0001104659-26-093723

Alert Tier

8